For many women, low libido has more than one cause, so PT-141 may be combined with treatments that address hormones, vaginal tissue health, pelvic floor concerns, or relationship and stress factors
Developed as type 2 diabetes treatments, glucagon-like peptide-1 (GLP-1) receptor agonists mimic the effects of GLP-1, a hormone produced naturally by the body to regulate hunger and blood sugar
Apto para personas celacas
Typically, treatment is initiated sequentially with metformin and sulphonylureas, followed by the incorporation of insulin, glucagon-like peptide-1 receptor agonists (GLP-1RAs), or dipeptidyl peptidase-4 (DPP-4) inhibitors
G.SiljeholmC.Di IorioA.De AmicisD.SaliniV.et al (2009)